TCHP Chemotherapy – What Patients Need to Know
This video explains the TCHP treatment plan for HER2-positive breast cancer in a simple, clear way. We cover:
What TCHP is: a combination of Taxotere (docetaxel), Carboplatin, Herceptin (trastuzumab), and Perjeta (pertuzumab)
How it’s given: every 3 weeks × 6 cycles; Herceptin + Perjeta may be continued to complete 1 year of therapy
Phesgo option: Herceptin + Perjeta can also be given together as a single subcutaneous injection
Tips for managing side effects and staying safe during treatment
Our goal is to help you understand your treatment, know what to expect, and feel supported every step of the way..